National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 41445-41446 [2024-10290]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 93 / Monday, May 13, 2024 / Notices
NCVHS website https://ncvhs.hhs.gov/,
where further information including an
agenda and instructions to access the
broadcast of the meeting will be posted.
Should you require reasonable
accommodation, please telephone the
CDC Office of Equal Employment
Opportunity at (770) 488–3210 as soon
as possible.
SUPPLEMENTARY INFORMATION: As
outlined in its Charter, the National
Committee on Vital and Health
Statistics assists and advises the
Secretary of HHS on health data, data
standards, statistics, privacy, national
health information policy, and the
Department’s strategy to best address
those issues. Under the Health
Insurance Portability and
Accountability Act of 1996 (HIPAA),1
NCVHS advises the Secretary on
administrative simplification standards,
including those for privacy, security,
adoption and implementation of
transaction standards, unique
identifiers, code sets, and operating
rules adopted under the Patient
Protection and Affordable Care Act
(ACA).2 Included in HIPAA is the
statutory reporting requirement that the
Committee submit to Congress and
make public, a report regarding the
implementation of part C of title XI of
the Social Security Act.
The meeting agenda will include
discussion of the NCVHS Report to
Congress. The Committee will reserve
time on the agenda for public comment.
Meeting times and topics are subject to
change. Please refer to the agenda
posted on the NCVHS website for
updates: https://ncvhs.hhs.gov/
meetings/full-committee-meeting-18/.
Sharon Arnold,
Associate Deputy Assistant Secretary, Office
of Science and Data Policy, Office of the
Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2024–10288 Filed 5–10–24; 8:45 am]
BILLING CODE 4150–05–P
meeting of the Board of Scientific
Counselors, National Cancer Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Cancer Institute.
Date: July 8–9, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Cancer Institute, 9609
Medical Center Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Brian E. Wojcik, Ph.D.,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive, Room
3W414, Rockville, MD 20850, 240–276–5660,
wojcikb@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsc/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 7, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–10293 Filed 5–10–24; 8:45 am]
BILLING CODE 4140–01–P
lotter on DSK11XQN23PROD with NOTICES1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Closed Meeting
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
1 Public
Law 104–191, 110 Stat. 1936 (Aug 21,
1996), available at https://www.congress.gov/104/
plaws/publ191/PLAW-104publ191.pdf.
2 Public Law 111–148, 124 Stat. 119, available at
https://www.congress.gov/111/plaws/publ148/
PLAW-111publ148.pdf.
VerDate Sep<11>2014
21:33 May 10, 2024
Jkt 262001
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
41445
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: June 13, 2024.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G56,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: Poonam Tewary, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G56, Rockville, MD
20852, (301) 761–7219, tewaryp@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 8, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–10376 Filed 5–10–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\13MYN1.SGM
13MYN1
41446
Federal Register / Vol. 89, No. 93 / Monday, May 13, 2024 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group: Arthritis and Musculoskeletal
and Skin Diseases Special Grants Study
Section.
Date: June 20–21, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015 (In-person Meeting).
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Extramural Program, National
Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Boulevard,
Room 820, Bethesda, MD 30892, 301–827–
7835, yasuko.furumoto@nih.gov.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group: Arthritis and Musculoskeletal
and Skin Diseases Clinical Trials Study
Section.
Date: June 27–28, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852 (In-person
Meeting).
Contact Person: Sushmita Purkayastha,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Extramural Program,
National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 814, Bethesda,
MD 20817, sushmita.purkayastha@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: May 7, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–10290 Filed 5–10–24; 8:45 am]
BILLING CODE 4140–01–P
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: The Impact
of Clinical Research Training and
Medical Education at the Clinical Center
on Physician Careers in Academia and
Clinical Research, OMB #0925–0602
Expiration Date: 6/30/2024, REVISION,
Clinical Center (CC), National Institutes
of Health (NIH).
Need and Use of Information
Collection: The information collected
will allow continued assessment of the
value of the training provided by the
Office of Clinical Research Training and
Medical Education (OCRTME) at the
NIH Clinical Center and the extent to
which this training promotes (a) patient
safety; (b) research productivity and
independence; and (c) future career
development within clinical,
translational, and academic research
settings. The information received from
respondents is presented to, evaluated
by, and incorporated into the ongoing
operational improvement efforts of the
Director of the Office of Clinical
Research Training and Education, and
the Chief Executive Officer of the NIH
Clinical Center. This information will
enable the ongoing operational
improvement efforts of the OCRTME
and its commitment to providing
clinical research training and medical
education of the highest quality to each
trainee. OMB approval is requested for
3 years. There are no costs to
respondents other than their time. The
total estimated annualized burden hours
537.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60 Day Comment
Request; The Impact of Clinical
Research Training and Medical
Education at the Clinical Center on
Physician Careers in Academia and
Clinical Research (Clinical Center)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, for opportunity
for public comment on proposed data
collection projects, the Clinical Center,
the National Institutes of Health (NIH)
will publish periodic summaries of
proposed projects to be submitted to the
Office of Management and Budget
(OMB) for review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
SUMMARY:
To
obtain a copy of the data collection
plans and instruments, contact: Tom
Burklow, MD, Office of Clinical
Research Training and Medical
Education, NIH Clinical Center,
National Institutes of Health, 10 Center
Drive, Room 1N262, Bethesda, MD
20892–1158, or call non-toll-free
number 301–435–8015, or Email your
request, including your address to:
tom.burklow@nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
FOR FURTHER INFORMATION CONTACT:
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Type of
respondents
Clinical Research Training Program/Medical
Research Scholars Program Alumni Survey.
Graduate Medical Education Graduate Survey
Clinical Electives Program 1 Year Alumni Survey.
Continuing Medical Education Evaluation Survey.
Physicians ........................
800
1
20/60
267
Physicians ........................
Physicians ........................
350
100
1
1
20/60
20/60
117
33
Physicians ........................
720
1
10/60
120
VerDate Sep<11>2014
21:33 May 10, 2024
Jkt 262001
PO 00000
Frm 00075
Fmt 4703
Number of
respondents
Number of
responses per
respondent
Form name
Sfmt 4703
E:\FR\FM\13MYN1.SGM
13MYN1
Total annual
burden hours
]]>Agencies
[Federal Register Volume 89, Number 93 (Monday, May 13, 2024)]
[Notices]
[Pages 41445-41446]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10290]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 41446]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Initial Review Group: Arthritis and Musculoskeletal and
Skin Diseases Special Grants Study Section.
Date: June 20-21, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015 (In-person Meeting).
Contact Person: Yasuko Furumoto, Ph.D., Scientific Review
Officer, Scientific Review Branch, Extramural Program, National
Institute of Arthritis and Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 820, Bethesda, MD 30892, 301-827-7835,
[email protected].
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Initial Review Group: Arthritis and Musculoskeletal and
Skin Diseases Clinical Trials Study Section.
Date: June 27-28, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD
20852 (In-person Meeting).
Contact Person: Sushmita Purkayastha, Ph.D., Scientific Review
Officer, Scientific Review Branch, Extramural Program, National
Institute of Arthritis and Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 814, Bethesda, MD 20817,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: May 7, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-10290 Filed 5-10-24; 8:45 am]
BILLING CODE 4140-01-P
